{'fraction_non_alphanumeric': 0.013084112149532711, 'fraction_numerical': 0.007476635514018692, 'mean_word_length': 5.457831325301205, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Malignant tumors of the spermatic cord

The clinical course of 10 patients with sarcoma of the spermatic cord is presented. The importance of spermatic cord and testicular invasion, the favorable role of retroperitoneal lymphadenectomy, and the promising results of aggressive chemotherapy for the invasive tumors are discussed. A patient with localized embryonal rhabdomyosarcoma of the spermatic cord who is still alive without any metastasis 39 years after initial therapy is, to our knowledge, the longest survivor of this disease.